# Translating real‐world evidence/real‐world data

**Authors:** Paulien Ravenstijn

PMC · DOI: 10.1111/cts.13835 · 2024-05-16

## Full-text entities

- **Genes:** UGT1A1 (UDP glucuronosyltransferase family 1 member A1) [NCBI Gene 54658] {aka BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT 1-1, UGT1}, CYP2D6 (cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)) [NCBI Gene 1565] {aka CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2}, CYP2C19 (cytochrome P450 family 2 subfamily C member 19) [NCBI Gene 1557] {aka CPCJ, CYP2C, CYPIIC17, CYPIIC19, P450C2C, P450IIC19}, CYP3A5 (cytochrome P450 family 3 subfamily A member 5) [NCBI Gene 1577] {aka CP35, CYPIIIA5, P450PCN3, PCN3}, CYP3A4 (cytochrome P450 family 3 subfamily A member 4) [NCBI Gene 1576] {aka CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4}, CYP2C9 (cytochrome P450 family 2 subfamily C member 9) [NCBI Gene 1559] {aka CPC9, CYP2C, CYP2C10, CYPIIC9, P450-2C9, P450IIC9}
- **Diseases:** sepsis (MESH:D018805), hypoglycemic adverse (MESH:C000721848), COVID-19 (MESH:D000086382), acute coronary syndrome (MESH:D054058), migraine (MESH:D008881), cancer (MESH:D009369), chronic coronary disease (MESH:D003327), death (MESH:D003643), liver cirrhosis (MESH:D008103), obesity (MESH:D009765), Type 2 diabetes mellitus (MESH:D003924), DMD (MESH:D020388), DDI (MESH:D000081015), cardiovascular diseases (MESH:D002318), hyperglycemia (MESH:D006943)
- **Chemicals:** creatinine (MESH:D003404), Tacrolimus (MESH:D016559), X (-), omeprazole (MESH:D009853), remdesivir (MESH:C000606551), esomeprazole (MESH:D064098), DPYD (MESH:C036020)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC11096809